{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:00:41Z","timestamp":1792119641032,"version":"4.4.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41577-023-00868-8","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T08:03:06Z","timestamp":1679385786000},"page":"267-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["We need to keep an eye on avian influenza"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-727X","authenticated-orcid":false,"given":"Stacey","family":"Schultz-Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"868_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1743-422X-10-139","volume":"10","author":"S Maurer-Stroh","year":"2013","unstructured":"Maurer-Stroh, S., Lee, R. T., Gunalan, V. & Eisenhaber, F. The highly pathogenic H7N3 avian influenza strain from July 2012 in Mexico acquired an extended cleavage site through recombination with host 28S rRNA. Virol. J. 10, 139 (2013).","journal-title":"Virol. J."},{"key":"868_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.virol.2017.04.025","volume":"507","author":"DH Lee","year":"2017","unstructured":"Lee, D. H., Torchetti, M. K., Killian, M. L. & Swayne, D. E. Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016. Virology 507, 216\u2013219 (2017).","journal-title":"Virology"},{"key":"868_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13567-018-0576-0","volume":"49","author":"K Bertran","year":"2018","unstructured":"Bertran, K. et al. Pathobiology of Tennessee 2017 H7N9 low and high pathogenicity avian influenza viruses in commercial broiler breeders and specific pathogen free layer chickens. Vet. Res. 49, 82 (2018).","journal-title":"Vet. Res."},{"key":"868_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.chom.2020.08.011","volume":"28","author":"S Herfst","year":"2020","unstructured":"Herfst, S. et al. Hemagglutinin traits determine transmission of avian A\/H10N7 influenza virus between mammals. Cell Host Microbe 28, 602\u2013613 (2020).","journal-title":"Cell Host Microbe"},{"key":"868_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/viro.1999.9820","volume":"261","author":"X Xu","year":"1999","unstructured":"Xu, X., Subbarao, K., Cox, N. J. & Guo, Y. Genetic characterization of the pathogenic influenza A\/Goose\/Guangdong\/1\/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261, 15\u201319 (1999).","journal-title":"Virology"},{"key":"868_CR6","unstructured":"World Health Organization. Avian influenza weekly update number 884. https:\/\/www.who.int\/docs\/default-source\/wpro---documents\/emergency\/surveillance\/avian-influenza\/ai_20230224.pdf?sfvrsn=5f006f99_111 (2023)."},{"key":"868_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.1218888","volume":"335","author":"TT Wang","year":"2012","unstructured":"Wang, T. T., Parides, M. K. & Palese, P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 335, 1463 (2012).","journal-title":"Science"},{"key":"868_CR8","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3201\/eid2812.221086","volume":"28","author":"A G\u00fcnther","year":"2022","unstructured":"G\u00fcnther, A. et al. Iceland as stepping stone for spread of highly pathogenic avian influenza virus between Europe and North America. Emerg. Infect. Dis. 28, 2383\u20132388 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"868_CR9","unstructured":"Centers for Disease Control and Prevention. Update on H5N1 bird flu in Cambodia. https:\/\/www.cdc.gov\/flu\/avianflu\/spotlights\/2022-2023\/avian-flu-cambodia.htm (2023)."},{"key":"868_CR10","doi-asserted-by":"publisher","first-page":"2300001","DOI":"10.2807\/1560-7917.ES.2023.28.3.2300001","volume":"28","author":"M Ag\u00fcero","year":"2023","unstructured":"Ag\u00fcero, M. et al. Highly pathogenic avian influenza A (H5N1) virus infection in farmed minks, Spain, October 2022. Euro Surveill. 28, 2300001 (2023).","journal-title":"Euro Surveill."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-023-00868-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-023-00868-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-023-00868-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:08:04Z","timestamp":1733940484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-023-00868-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1038\/s41577-023-00868-8","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"assertion":[{"value":"21 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.K. has been consulting for Curevac, Seqirus and Merck and is currently consulting for Pfizer, Third Rock Ventures, Avimex and GSK. He is named on several patents regarding influenza virus and SARS-CoV-2 vaccines, influenza virus therapeutics and SARS-CoV-2 serological tests. Some of these technologies have been licensed to commercial entities and F.K. is receiving royalties from these entities. F.K. is also an advisory board member of Castlevax, a spin-off company formed by the Icahn School of Medicine at Mount Sinai to develop SARS-CoV-2 vaccines. The Krammer laboratory has received funding for research projects from Pfizer, GSK and Dynavax and three of F.K.\u2019s mentees have recently joined Moderna. S.S.-C. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}